Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

95 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Uncovering novel targets for cancer chemoprevention.
Dragnev KH, Feng Q, Ma Y, Shah SJ, Black C, Memoli V, Nugent W, Rigas JR, Kitareewan S, Freemantle S, Dmitrovsky E. Dragnev KH, et al. Among authors: freemantle s. Recent Results Cancer Res. 2007;174:235-43. doi: 10.1007/978-3-540-37696-5_21. Recent Results Cancer Res. 2007. PMID: 17302201 Review.
Cyclin degradation for cancer therapy and chemoprevention.
Freemantle SJ, Liu X, Feng Q, Galimberti F, Blumen S, Sekula D, Kitareewan S, Dragnev KH, Dmitrovsky E. Freemantle SJ, et al. J Cell Biochem. 2007 Nov 1;102(4):869-77. doi: 10.1002/jcb.21519. J Cell Biochem. 2007. PMID: 17868090 Review.
Retinoid chemoprevention trials: cyclin D1 in the crosshairs.
Freemantle SJ, Guo Y, Dmitrovsky E. Freemantle SJ, et al. Cancer Prev Res (Phila). 2009 Jan;2(1):3-6. doi: 10.1158/1940-6207.CAPR-08-0218. Cancer Prev Res (Phila). 2009. PMID: 19139010 Free PMC article. Review. No abstract available.
Uncovering growth-suppressive MicroRNAs in lung cancer.
Liu X, Sempere LF, Galimberti F, Freemantle SJ, Black C, Dragnev KH, Ma Y, Fiering S, Memoli V, Li H, DiRenzo J, Korc M, Cole CN, Bak M, Kauppinen S, Dmitrovsky E. Liu X, et al. Among authors: freemantle sj. Clin Cancer Res. 2009 Feb 15;15(4):1177-83. doi: 10.1158/1078-0432.CCR-08-1355. Clin Cancer Res. 2009. PMID: 19228723 Free PMC article.
Bexarotene plus erlotinib suppress lung carcinogenesis independent of KRAS mutations in two clinical trials and transgenic models.
Dragnev KH, Ma T, Cyrus J, Galimberti F, Memoli V, Busch AM, Tsongalis GJ, Seltzer M, Johnstone D, Erkmen CP, Nugent W, Rigas JR, Liu X, Freemantle SJ, Kurie JM, Waxman S, Dmitrovsky E. Dragnev KH, et al. Among authors: freemantle sj. Cancer Prev Res (Phila). 2011 Jun;4(6):818-28. doi: 10.1158/1940-6207.CAPR-10-0376. Cancer Prev Res (Phila). 2011. PMID: 21636548 Free PMC article. Clinical Trial.
CDK2 Inhibition Causes Anaphase Catastrophe in Lung Cancer through the Centrosomal Protein CP110.
Hu S, Danilov AV, Godek K, Orr B, Tafe LJ, Rodriguez-Canales J, Behrens C, Mino B, Moran CA, Memoli VA, Mustachio LM, Galimberti F, Ravi S, DeCastro A, Lu Y, Sekula D, Andrew AS, Wistuba II, Freemantle S, Compton DA, Dmitrovsky E. Hu S, et al. Among authors: freemantle s. Cancer Res. 2015 May 15;75(10):2029-38. doi: 10.1158/0008-5472.CAN-14-1494. Epub 2015 Mar 25. Cancer Res. 2015. PMID: 25808870 Free PMC article.
95 results